Correlation Between Vir Biotechnology and Fate Therapeutics

Can any of the company-specific risk be diversified away by investing in both Vir Biotechnology and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vir Biotechnology and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vir Biotechnology and Fate Therapeutics, you can compare the effects of market volatilities on Vir Biotechnology and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vir Biotechnology with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vir Biotechnology and Fate Therapeutics.

Diversification Opportunities for Vir Biotechnology and Fate Therapeutics

0.02

Correlation Coefficient

Vir Biotechnology  Fate Therapeutics

Significant diversification

The 3 months correlation between Vir and Fate is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Vir Biotechnology and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Vir Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vir Biotechnology are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Vir Biotechnology i.e., Vir Biotechnology and Fate Therapeutics go up and down completely randomly.

Pair Corralation between Vir Biotechnology and Fate Therapeutics

Considering the 90-day investment horizon Vir Biotechnology is expected to generate 0.71 times more return on investment than Fate Therapeutics. However, Vir Biotechnology is 1.4 times less risky than Fate Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.46 per unit of risk. If you would invest  786.00  in Vir Biotechnology on September 28, 2024 and sell it today you would lose (46.00) from holding Vir Biotechnology or give up 5.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vir Biotechnology  vs.  Fate Therapeutics

Vir Biotechnology

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable forward indicators, Vir Biotechnology is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Fate Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Vir Biotechnology and Fate Therapeutics

The main advantage of trading using opposite Vir Biotechnology and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vir Biotechnology position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.

The idea behind Vir Biotechnology and Fate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.